## 15-Hydroperoxy-5,8,11,13-eicosatetraenoic acid (s)-(e,z,z,z)-isomer: A Key Player in Inflammation and Beyond
**15-Hydroperoxy-5,8,11,13-eicosatetraenoic acid (15-HPETE)** is a crucial lipid mediator that plays a significant role in various biological processes, especially **inflammation**, making it a cornerstone for researchers in various fields. Let's break down the compound and its significance:
**What it is:**
* **15-HPETE:** A fatty acid derivative of arachidonic acid.
* **Hydroperoxy:** Contains a peroxide group (-OOH) at the 15th carbon.
* **(s)-(e,z,z,z)-isomer:** This specific isomer refers to the configuration of the double bonds and the chiral center.
* **(s):** The chiral center at carbon 15 has a specific stereochemical configuration.
* **(e,z,z,z):** Refers to the configuration of the double bonds, with 'e' denoting a trans (opposite) configuration and 'z' denoting a cis (same) configuration.
**Why it is important:**
**1. Inflammation:** 15-HPETE is a key intermediate in the **arachidonic acid cascade**, a complex signaling pathway leading to the production of various inflammatory mediators like **leukotrienes**, **prostaglandins**, and **thromboxanes**. These mediators are involved in diverse inflammatory responses, from pain and swelling to immune cell recruitment. Understanding the role of 15-HPETE in this pathway is critical for developing **anti-inflammatory drugs**.
**2. Vascular Biology:** 15-HPETE contributes to **vasoconstriction**, narrowing blood vessels. This effect can impact blood pressure and potentially contribute to cardiovascular disease.
**3. Cancer:** 15-HPETE has been implicated in **cancer cell proliferation** and **angiogenesis**, the formation of new blood vessels that supply tumors. Research aims to uncover the specific mechanisms of 15-HPETE's involvement in cancer development and explore its potential as a **therapeutic target**.
**4. Nervous System:** 15-HPETE plays a role in **neurotransmission** and **neuroprotection**. Some studies suggest it can modulate neuronal activity and influence the central nervous system.
**5. Other research areas:** 15-HPETE is also being investigated for its roles in:
* **Immune system regulation:** modulating immune cell responses.
* **Wound healing:** impacting the healing process.
* **Asthma:** contributing to airway inflammation.
**Research focus:**
Scientists are actively investigating:
* **Metabolic pathways:** How 15-HPETE is synthesized and metabolized.
* **Cellular signaling:** How 15-HPETE interacts with specific receptors and triggers downstream signaling events.
* **Therapeutic potential:** Exploring 15-HPETE as a target for drug development.
**In summary:** 15-HPETE (s)-(e,z,z,z)-isomer is a crucial lipid mediator with diverse biological functions, particularly in inflammation. Its role in various physiological processes makes it a significant target for research in areas like medicine, biology, and pharmacology, offering potential avenues for developing new therapies and improving our understanding of human health.
HPETE : Mono-hydroperoxy (e)icosatetraenoic acids (HPETEs) are the primary products of lipoxygenase-catalysed oxygenation of arachidonic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
15(S)-HPETE : The (S)-enantiomer of 15-HPETE. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
ID Source | ID |
---|---|
PubMed CID | 5280893 |
CHEMBL ID | 1606580 |
CHEBI ID | 15628 |
SCHEMBL ID | 4329512 |
MeSH ID | M0316139 |
Synonym |
---|
70981-96-3 |
7bn3o939p6 , |
15-hpete, (s)- |
(s-(e,z,z,z))-15-hydroperoxy-5,8,11,13-eicosatetraenoic acid |
unii-7bn3o939p6 |
5,8,11,13-eicosatetraenoic acid, 15-hydroperoxy-, (s-(e,z,z,z))- |
gtpl2482 |
(5z,8z,11z,13e,15s)-15-hydroperoxyicosa-5,8,11,13-tetraenoic acid |
15s-hpete |
CHEBI:15628 , |
LMFA03060014 |
15s-hydroperoxy-5z,8z,11z,13e-eicosatetraenoic acid |
IDI1_033809 |
15-hydroperoxyicosatetraenoate |
(5z,8z,11z,13e)-(15s)-15-hydroperoxyicosa-5,8,11,13-tetraenoate |
15(s)-hpete |
(5z,8z,11z,13e)-(15s)-15-hydroperoxyicosa-5,8,11,13-tetraenoic acid |
15-hydroperoxyeicosatetraenoate |
C05966 |
15-hydroperoxyeicosatetraenoic acid |
15-hydroperoxyicosatetraenoic acid |
15(s)-hydroperoxy-(5z,8z,11z,13e)-eicosatetraenoic acid, ~100 mug/ml in ethanol, >=95% |
NCGC00161251-02 |
NCGC00161251-01 |
BSPBIO_001339 |
NCGC00161251-03 |
HMS1989C21 |
BML1-C06 |
HMS1361C21 |
HMS1791C21 |
SCHEMBL4329512 |
bdbm50025742 |
chembl1606580 , |
(s)-15-hydroperoxy-icosa-5,8,11,13-tetraenoic acid(15(s)-ooh-20 : 4) |
5,8,11,13-eicosatetraenoicacid, 15-hydroperoxy-, (5z,8z,11z,13e,15s)- |
15(s)-hydroperoxy-(5z,8z,11z,13e)-eicosatetraenoic acid |
BFWYTORDSFIVKP-VAEKSGALSA-N |
hpete |
15-hydroperoxyeicosatetraenoic acid, (5z,8z,11z,13e,15s)- |
5,8,11,13-eicosatetraenoic acid, 15-hydroperoxy-, (5z,8z,11z,13e,15s)- |
(5z,8z,11z,13e,15s)-15-hydroperoxy-5,8,11,13-eicosatetraenoic acid |
15-hydroperoxyarachidonic acid, (s)- |
HMS3402C21 |
15s-hydroperoxyeicosatetraenoic acid |
15s-hydroperoxyeicosatetraenoate |
5,8,11,13-eicosatetraenoicacid,15-hydroperoxy-,(5z,8z,11z,13e,15s)- |
(s)-15-hpete |
Q27070784 |
15(s)-hpete lipid maps(r) ms standard |
DTXSID301318203 |
AKOS040754944 |
Role | Description |
---|---|
mouse metabolite | Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
15-HPETE | A HPETE that consists of (5Z,8Z,11Z,13E)-icosatetraenoic acid in which the hydroperoxy group is located at position 15. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 18.8876 | 0.5318 | 15.4358 | 37.6858 | AID504845 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | IC50 (µMol) | 3.4000 | 0.0046 | 2.0182 | 10.0000 | AID6794 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4 | A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49 | Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
AID6794 | Inhibition of rat basophilic leukemia-1 (RBL-1) 5-lipoxygenase | 1987 | Journal of medicinal chemistry, Feb, Volume: 30, Issue:2 | Structural requirements for the inhibition of 5-lipoxygenase by 15-hydroxyeicosa-5,8,11,13-tetraenoic acid analogues. |
AID1346643 | Rat TRPV1 (Transient Receptor Potential channels) | 2000 | Proceedings of the National Academy of Sciences of the United States of America, May-23, Volume: 97, Issue:11 | Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.92) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |